GWAS1490955_H |
GCST008685 |
HDL cholesterol levels |
up to 23,761 African ancestry individuals, 13,171 Asian ancestry individuals, up to 90,272 European ancestry individuals, 6,620 Hispanic individuals |
A |
0.4113 |
1E-65 |
65 |
rs1532085 |
0.0185 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:30926973 |
GWAS1113081_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.378 |
2E-20 |
19.699 |
rs1532085 |
0.044 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
GWAS1113082_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.49 |
7E-10 |
9.155 |
rs1532085 |
0.097 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
GWAS1113585_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-42 |
41.699 |
rs1532085 |
0.06431696 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1726183_H |
GCST009367 |
HDL cholesterol levels x short total sleep time interaction (2df test) |
3,007 African American short sleepers, 369 Chinese ancestry short sleepers, 114 Asian ancestry short sleepers, at least 8,474 European ancestry short sleepers, 1,082 Hispanic/Latino short sleepers, up to 11,901 African American controls, 1,444 Chinese ancestry controls, 452 Asian ancestry controls, at least 31,567 European ancestry controls, 4,047 Hispanic/Latino controls |
? |
NR |
2E-83 |
82.699 |
rs1532085 |
0.01819 |
sleep duration trait (OBA:2040171) high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:31719535 |
GWAS1668993_H |
GCST90480669 |
red blood cell count (RBC, mean, inv-norm transformed) |
114,768 African American or Afro-Caribbean individuals, 55,750 Hispanic or Latin American individuals, 5,943 East Asian ancestry individuals, 405,366 European ancestry individuals |
A |
0.4065 |
9E-13 |
12.046 |
rs1532085 |
0.01925 |
erythrocyte count (EFO:0004305)
|
PMID:39024449 |
GWAS1748630_H |
GCST90093051 |
Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL |
111,638 European ancestry individuals |
A |
0.384918 |
2E-155 |
154.699 |
rs1532085 |
0.113642 |
triglycerides:total lipids ratio (EFO:0020947) blood VLDL cholesterol amount (OBA:VT0005144) chylomicron amount (OBA:2050296)
|
PMID:35213538 |
GWAS1755813_H |
GCST90302149 |
Triglycerides to total lipids ratio in very large VLDL |
4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 110,896 European ancestry individuals |
A |
0.4111 |
6E-61 |
60.222 |
rs1532085 |
0.0726 |
triglycerides:total lipids ratio (EFO:0020947) blood VLDL cholesterol amount (OBA:VT0005144)
|
PMID:38448586 |
GWAS1757574_H |
GCST90093041 |
Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL |
111,638 European ancestry individuals |
A |
0.384918 |
7E-113 |
112.155 |
rs1532085 |
0.0960421 |
cholesterol:total lipids ratio (EFO:0020943) blood VLDL cholesterol amount (OBA:VT0005144) chylomicron amount (OBA:2050296)
|
PMID:35213538 |
GWAS1757764_H |
GCST90093043 |
Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL |
111,638 European ancestry individuals |
A |
0.384918 |
8E-81 |
80.097 |
rs1532085 |
0.0814245 |
cholesteryl esters:total lipids ratio (EFO:0020944) blood VLDL cholesterol amount (OBA:VT0005144) chylomicron amount (OBA:2050296)
|
PMID:35213538 |
GWAS1758984_H |
GCST90093045 |
Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL |
111,638 European ancestry individuals |
A |
0.384918 |
2E-144 |
143.699 |
rs1532085 |
0.108126 |
free cholesterol:total lipids ratio (EFO:0020945) blood VLDL cholesterol amount (OBA:VT0005144) chylomicron amount (OBA:2050296)
|
PMID:35213538 |
GWAS1760066_H |
GCST90092869 |
Cholesterol to total lipids ratio in large VLDL |
115,071 European ancestry individuals |
A |
0.386036 |
2E-168 |
167.699 |
rs1532085 |
0.114602 |
cholesterol:total lipids ratio (EFO:0020943) blood VLDL cholesterol amount (OBA:VT0005144)
|
PMID:35213538 |
GWAS1766741_H |
GCST90239613 |
Very low density lipoprotein cholesterol levels |
75,388 Taiwanese ancestry individuals |
? |
NR |
2E-78 |
77.699 |
rs1532085 |
1.37233 |
blood VLDL cholesterol amount (OBA:VT0005144)
|
PMID:36329257 |
GWAS1451509_H |
GCST001765 |
Red blood cell traits |
62,553 European ancestry individuals, 9,308 South Asian ancestry individuals |
G |
0.59 |
7E-11 |
10.155 |
rs1532085 |
0.034 |
hemoglobin measurement (EFO:0004509)
|
PMID:23222517 |
GWAS1452217_H |
GCST000533 |
Lipid metabolism phenotypes |
Up to 17,296 European ancestry female individuals |
? |
NR |
4E-16 |
15.398 |
rs1532085 |
0.112 |
lipid measurement (EFO:0004529)
|
PMID:19936222 |
GWAS1452478_H |
GCST000533 |
Lipid metabolism phenotypes |
Up to 17,296 European ancestry female individuals |
? |
NR |
1E-19 |
19 |
rs1532085 |
0.107 |
lipid measurement (EFO:0004529)
|
PMID:19936222 |
GWAS1452479_H |
GCST000533 |
Lipid metabolism phenotypes |
Up to 17,296 European ancestry female individuals |
? |
NR |
9E-15 |
14.046 |
rs1532085 |
1.421 |
lipid measurement (EFO:0004529)
|
PMID:19936222 |
GWAS1452734_H |
GCST001639 |
Metabolite levels |
6,608 European ancestry individuals |
? |
0.44 |
9E-104 |
103.046 |
rs1532085 |
N/A |
coronary artery calcification (EFO:0004723)
|
PMID:22916037 |
GWAS1459212_H |
GCST004232 |
HDL cholesterol levels |
34,930 East Asian ancestry individuals, 187,167 European ancestry individuals |
A |
0.367 |
1E-213 |
213 |
rs1532085 |
0.107 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:28334899 |
GWAS1461014_H |
GCST008702 |
Triglyceride levels |
up to 23,508 African ancestry individuals, 4,649 Asian ancestry individuals, up to 77,047 European ancestry individuals, 6,705 Hispanic individuals |
A |
0.4038 |
9E-8 |
7.046 |
rs1532085 |
0.013 |
triglyceride measurement (EFO:0004530)
|
PMID:30926973 |
GWAS1462294_H |
GCST90444489 |
Metabolic syndrome |
10,684 Korean ancestry cases, 51,630 Korean ancestry controls |
? |
NR |
2E-8 |
7.699 |
rs1532085 |
0.0856822 |
metabolic syndrome (EFO:0000195)
|
PMID:39349817 |
GWAS1466501_H |
GCST001436 |
Metabolic syndrome |
2,637 European ancestry cases, 7,927 European ancestry controls |
G |
0.57 |
5E-24 |
23.302 |
rs1532085 |
0.13 |
metabolic syndrome (EFO:0000195)
|
PMID:22399527 |
GWAS1466668_H |
GCST009918 |
HDL cholesterol levels |
12,685 Chinese ancestry individuals |
G |
0.544 |
6E-16 |
15.222 |
rs1532085 |
0.104 |
HDL cholesterol change measurement (EFO:0007805)
|
PMID:26690388 |
GWAS1469133_H |
GCST000284 |
HDL cholesterol |
4,763 Northern Finnish founder individuals |
A |
0.44 |
2E-10 |
9.699 |
rs1532085 |
0.05 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:19060910 |
GWAS1473397_H |
GCST002221 |
Cholesterol, total |
94,595 European ancestry individuals |
A |
0.40 |
7E-47 |
46.155 |
rs1532085 |
0.054 |
total cholesterol measurement (EFO:0004574)
|
PMID:24097068 |
GWAS1473443_H |
GCST002216 |
Triglycerides |
94,595 European ancestry individuals |
A |
0.40 |
2E-18 |
17.699 |
rs1532085 |
0.031 |
triglyceride measurement (EFO:0004530)
|
PMID:24097068 |
GWAS1778451_H |
GCST90092871 |
Cholesteryl esters to total lipids ratio in large VLDL |
115,071 European ancestry individuals |
A |
0.386036 |
9E-171 |
170.046 |
rs1532085 |
0.113009 |
cholesteryl esters:total lipids ratio (EFO:0020944) blood VLDL cholesterol amount (OBA:VT0005144)
|
PMID:35213538 |
GWAS1473722_H |
GCST002223 |
HDL cholesterol |
94,595 European ancestry individuals |
A |
0.4 |
1E-188 |
188 |
rs1532085 |
0.107 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:24097068 |
GWAS1473978_H |
GCST000760 |
Cholesterol, total |
100,184 European ancestry individuals |
A |
0.39 |
9E-20 |
19.046 |
rs1532085 |
1.54 |
total cholesterol measurement (EFO:0004574)
|
PMID:20686565 |
GWAS1474011_H |
GCST000285 |
Cholesterol, total |
21,848 European ancestry individuals, 714 Orcadian individuals |
G |
0.59 |
4E-7 |
6.398 |
rs1532085 |
0.05 |
total cholesterol measurement (EFO:0004574)
|
PMID:19060911 |
GWAS1474021_H |
GCST000288 |
HDL cholesterol |
20,697 European ancestry individuals, 715 Orcadian individuals |
G |
0.59 |
1E-35 |
35 |
rs1532085 |
0.13 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:19060911 |
GWAS1474307_H |
GCST000755 |
HDL cholesterol |
99,900 European ancestry individuals |
A |
0.39 |
3E-96 |
95.523 |
rs1532085 |
1.45 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:20686565 |
GWAS1474313_H |
GCST000758 |
Triglycerides |
96,598 European ancestry individuals |
G |
0.22 |
2E-13 |
12.699 |
rs1532085 |
2.99 |
triglyceride measurement (EFO:0004530)
|
PMID:20686565 |
GWAS1475391_H |
GCST009391 |
Metabolite levels |
2,076 European ancestry individuals |
? |
NR |
4E-12 |
11.398 |
rs1532085 |
0.24211231 |
lysophosphatidylethanolamine 16:0 measurement (EFO:0010366)
|
PMID:23823483 |
GWAS1485720_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
9E-45 |
44.046 |
rs1532085 |
0.14934805 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486036_H |
GCST010083 |
Hemoglobin levels |
684,122 European ancestry individuals |
A |
NR |
4E-15 |
14.398 |
rs1532085 |
0.017 |
hemoglobin measurement (EFO:0004509)
|
PMID:32327693 |
GWAS1486048_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
5E-50 |
49.302 |
rs1532085 |
0.11360955 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486338_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-9 |
8.523 |
rs1532085 |
0.074650936 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486672_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-9 |
8.398 |
rs1532085 |
0.08684096 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486676_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-9 |
8.155 |
rs1532085 |
0.0853106 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486685_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-8 |
8 |
rs1532085 |
0.0835205 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-8 |
7.699 |
rs1532085 |
0.08348236 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486716_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-13 |
12.155 |
rs1532085 |
0.08955071 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-13 |
12.155 |
rs1532085 |
0.105751224 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1486719_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-12 |
12 |
rs1532085 |
0.10512086 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-18 |
17.699 |
rs1532085 |
0.116394006 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1487071_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-15 |
14.699 |
rs1532085 |
0.10680944 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1487079_H |
GCST010244 |
Triglyceride levels |
441,016 European ancestry individuals |
A |
0.386452 |
3E-51 |
50.523 |
rs1532085 |
0.0308141 |
triglyceride measurement (EFO:0004530)
|
PMID:32203549 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-10 |
9.699 |
rs1532085 |
0.09398883 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-13 |
12.699 |
rs1532085 |
0.07723854 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1487381_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
3E-16 |
15.523 |
rs1532085 |
0.107279025 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1487384_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
9E-32 |
31.046 |
rs1532085 |
0.1045856 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1487690_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-8 |
7.398 |
rs1532085 |
0.081478536 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488361_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-13 |
13 |
rs1532085 |
0.049979195 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488364_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-9 |
9 |
rs1532085 |
0.04766495 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-10 |
9.699 |
rs1532085 |
0.055791527 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488366_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
3E-11 |
10.523 |
rs1532085 |
0.062062085 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-12 |
12 |
rs1532085 |
0.06319349 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488495_H |
GCST010245 |
LDL cholesterol levels |
440,546 European ancestry individuals |
A |
0.386409 |
9E-16 |
15.046 |
rs1532085 |
0.017242 |
low density lipoprotein cholesterol measurement (EFO:0004611)
|
PMID:32203549 |
GWAS1488659_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-7 |
7 |
rs1532085 |
0.07799091 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488663_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-7 |
6.699 |
rs1532085 |
0.07733865 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-7 |
6.699 |
rs1532085 |
0.076431885 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488684_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-33 |
32.699 |
rs1532085 |
0.08897158 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488689_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
5E-23 |
22.302 |
rs1532085 |
0.0951767 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488711_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-42 |
41.523 |
rs1532085 |
0.16935521 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488714_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-32 |
31.398 |
rs1532085 |
0.14359534 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488717_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-25 |
24.398 |
rs1532085 |
0.13007617 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488718_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-24 |
23.699 |
rs1532085 |
0.1499714 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488722_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-23 |
22.523 |
rs1532085 |
0.14599411 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1488997_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
6E-74 |
73.222 |
rs1532085 |
0.1949246 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489001_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
4E-47 |
46.398 |
rs1532085 |
0.16946794 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489012_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-22 |
21.699 |
rs1532085 |
0.120991126 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489275_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
0.000005 |
5.302 |
rs1532085 |
0.06735248 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489284_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
3E-19 |
18.523 |
rs1532085 |
0.084320836 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489628_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-36 |
36 |
rs1532085 |
0.11400284 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489630_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-10 |
10 |
rs1532085 |
0.0629485 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489634_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
3E-29 |
28.523 |
rs1532085 |
0.054096222 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489637_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
6E-19 |
18.222 |
rs1532085 |
0.060541064 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-15 |
14.699 |
rs1532085 |
0.11655516 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489659_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-15 |
14.155 |
rs1532085 |
0.11560253 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489665_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-17 |
16.155 |
rs1532085 |
0.1229284 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489674_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
7E-61 |
60.155 |
rs1532085 |
0.20530656 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489920_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-14 |
13.523 |
rs1532085 |
0.09308377 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-13 |
12.699 |
rs1532085 |
0.10960441 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489944_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
3E-48 |
47.523 |
rs1532085 |
0.10953996 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1489946_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-21 |
21 |
rs1532085 |
0.08734269 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490303_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
4E-18 |
17.398 |
rs1532085 |
0.076837495 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
4E-16 |
15.398 |
rs1532085 |
0.06878999 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490306_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
5E-46 |
45.302 |
rs1532085 |
0.095103495 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490308_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
8E-12 |
11.097 |
rs1532085 |
0.07904208 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490312_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
6E-11 |
10.222 |
rs1532085 |
0.07166508 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490326_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
5E-32 |
31.302 |
rs1532085 |
0.09050984 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490331_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-50 |
50 |
rs1532085 |
0.1423958 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490336_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
0.000002 |
5.699 |
rs1532085 |
0.069876485 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-15 |
14.699 |
rs1532085 |
0.07249342 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490666_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-58 |
58 |
rs1532085 |
0.13074026 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1490667_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-49 |
48.699 |
rs1532085 |
0.15250725 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS1495065_H |
GCST90132636 |
Triglyceride levels in very large HDL |
21,536 European ancestry individuals |
G |
0.6 |
9E-155 |
154.046 |
rs1532085 |
0.26 |
triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:27005778 |
GWAS1499482_H |
GCST008035 |
High density lipoprotein cholesterol levels |
10,085 African American individuals, 17,751 Hispanic/Latino individuals, 2,378 Asian ancestry individuals, 1,912 Native Hawaiian ancestry individuals, 604 Native American ancestry individuals, 333 individuals |
? |
NR |
9E-25 |
24.046 |
rs1532085 |
1.156662 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:31217584 |
None Available |
GCST90140946 |
HDL cholesterol levels |
22,000 Pakistani and Bangladeshi ancestry individuals |
G |
0.46 |
6E-11 |
10.222 |
rs1532085 |
0.07 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:35945198 |
GWAS1506972_H |
GCST009777 |
C-reactive protein levels |
418,642 British ancestry individuals |
A |
0.386461 |
3E-13 |
12.523 |
rs1532085 |
0.0149827 |
C-reactive protein measurement (EFO:0004458)
|
PMID:31900758 |
GWAS1508493_H |
GCST006306 |
HDL cholesterol |
1,017 Yoruban ancestry individuals, 1,765 Filipino ancestry individuals |
A |
0.403 |
0.000008 |
5.097 |
rs1532085 |
1.634 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29404214 |
None Available |
GCST90060137 |
Lysophosphatidylethanolamine_16:0_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
1E-12 |
12 |
rs1532085 |
0.07781 |
lysophosphatidylethanolamine measurement (EFO:0010225)
|
PMID:34503513 |
GWAS1514309_H |
GCST90060273 |
Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
6E-112 |
111.222 |
rs1532085 |
0.270885 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
None Available |
GCST90060319 |
Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
4E-12 |
11.398 |
rs1532085 |
0.0712708 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1514668_H |
GCST90060312 |
Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
7E-93 |
92.155 |
rs1532085 |
0.253177 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1514951_H |
GCST90060316 |
Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
4E-106 |
105.398 |
rs1532085 |
0.256735 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1521416_H |
GCST90060272 |
Phosphatidylethanolamine_36:4_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
9E-86 |
85.046 |
rs1532085 |
0.228901 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1521484_H |
GCST90060310 |
Phosphatidylethanolamine_38:6_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
9E-100 |
99.046 |
rs1532085 |
0.250514 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1521584_H |
GCST90060247 |
Phosphatidylethanolamine_34:2_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
5E-47 |
46.302 |
rs1532085 |
0.168228 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1521938_H |
GCST90060690 |
Phosphatidylethanolamine(36:4)_[M+H]1+ levels |
5,662 Pakistani ancestry individuals |
C |
NR |
6E-24 |
23.222 |
rs1532085 |
0.0523 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1522057_H |
GCST90060199 |
Diacylglycerol_38:6_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
A |
NR |
7E-21 |
20.155 |
rs1532085 |
0.0954561 |
diglyceride measurement (EFO:0010223)
|
PMID:34503513 |
None Available |
GCST90060738 |
Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels |
5,662 Pakistani ancestry individuals |
T |
NR |
6E-24 |
23.222 |
rs1532085 |
0.0694 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1522090_H |
GCST90060274 |
Phosphatidylethanolamine_36:3_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
6E-20 |
19.222 |
rs1532085 |
0.0962101 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060200 |
Diacylglycerol_38:5_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
A |
NR |
1E-12 |
12 |
rs1532085 |
0.0598281 |
diacylglycerol 38:5 measurement (EFO:0020067)
|
PMID:34503513 |
None Available |
GCST90060689 |
Phosphatidylethanolamine(36:4)_[M-H]1- levels |
5,662 Pakistani ancestry individuals |
A |
NR |
6E-24 |
23.222 |
rs1532085 |
0.1172 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060790 |
Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels |
5,662 Pakistani ancestry individuals |
A |
NR |
6E-24 |
23.222 |
rs1532085 |
0.0938 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
None Available |
GCST90060665 |
Phosphatidylethanolamine(34:2)_[M+H]1+ levels |
5,662 Pakistani ancestry individuals |
A |
NR |
6E-24 |
23.222 |
rs1532085 |
0.103 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060692 |
Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels |
5,662 Pakistani ancestry individuals |
G |
NR |
6E-24 |
23.222 |
rs1532085 |
0.0777 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1523825_H |
GCST90060777 |
Phosphatidylethanolamine(40:7)_[M-H]1- levels |
5,662 Pakistani ancestry individuals |
A |
NR |
7E-24 |
23.155 |
rs1532085 |
0.0795 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060696 |
Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels |
5,662 Pakistani ancestry individuals |
T |
NR |
6E-24 |
23.222 |
rs1532085 |
0.1429 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1523944_H |
GCST90060249 |
Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
5E-75 |
74.302 |
rs1532085 |
0.225862 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1524445_H |
GCST90060371 |
Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels |
13,814 British ancestry individuals |
A |
NR |
1E-39 |
39 |
rs1532085 |
0.194144 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS1524461_H |
GCST90060315 |
Phosphatidylethanolamine_38:4_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
3E-15 |
14.523 |
rs1532085 |
0.0666864 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060733 |
Phosphatidylethanolamine(38:5)_[M-H]1- levels |
5,662 Pakistani ancestry individuals |
A |
NR |
7E-24 |
23.155 |
rs1532085 |
0.0722 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1524630_H |
GCST90060313 |
Phosphatidylethanolamine_38:5_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
3E-27 |
26.523 |
rs1532085 |
0.109679 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
None Available |
GCST90060699 |
Phosphatidate(39:1)_[M+H]1+ levels |
5,662 Pakistani ancestry individuals |
T |
NR |
7E-24 |
23.155 |
rs1532085 |
0.0602 |
phosphatidate measurement (EFO:0020047)
|
PMID:34503513 |
None Available |
GCST90060250 |
Phosphatidylethanolamine_34:1_[M-H]1- levels |
13,814 British ancestry individuals |
A |
NR |
2E-15 |
14.699 |
rs1532085 |
0.0827329 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:34503513 |
GWAS1532154_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.378 |
4E-98 |
97.398 |
rs1532085 |
0.081 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS1532417_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.376 |
0.000007 |
5.155 |
rs1532085 |
0.057 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS1532418_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.49 |
2E-12 |
11.699 |
rs1532085 |
0.093 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS1532419_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.52 |
0.000004 |
5.398 |
rs1532085 |
0.098 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS1532420_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
NR |
2E-116 |
115.699 |
rs1532085 |
0.08 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS1534548_H |
GCST90092994 |
Degree of unsaturation |
115,006 European ancestry individuals |
A |
0.386032 |
4E-22 |
21.398 |
rs1532085 |
0.0389563 |
fatty acid measurement (EFO:0005110)
|
PMID:35213538 |
GWAS1535944_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
NR |
2E-27 |
26.699 |
rs1532085 |
0.046 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
None Available |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.378 |
8E-12 |
11.097 |
rs1532085 |
0.029 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS1536238_H |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
0.49 |
8E-9 |
8.097 |
rs1532085 |
0.083 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS1536239_H |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
A |
NR |
2E-19 |
18.699 |
rs1532085 |
0.035 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS1536586_H |
GCST90092817 |
Ratio of docosahexaenoic acid to total fatty acid levels |
115,006 European ancestry individuals |
A |
0.386032 |
1E-45 |
45 |
rs1532085 |
0.0581405 |
docosahexaenoic acid measurement (EFO:0007761) fatty acid measurement (EFO:0005110)
|
PMID:35213538 |
GWAS1538359_H |
GCST90090989 |
High density lipoprotein cholesterol levels |
17,641 African American individuals, 22,830 Hispanics ancestry individuals, 2,378 East Asian ancestry individuals, 1,912 Native Hawaiian ancestry individuals, 604 Native American ancestry individuals, 333 individuals, 22,887 European ancestry individuals |
? |
NR |
6E-25 |
24.222 |
rs1532085 |
0.082 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:32226016 |
GWAS1540972_H |
GCST90092932 |
Ratio of omega-3 fatty acids to total fatty acids |
115,006 European ancestry individuals |
A |
0.386032 |
3E-82 |
81.523 |
rs1532085 |
0.078198 |
fatty acid measurement (EFO:0005110)
|
PMID:35213538 |
None Available |
GCST90020244 |
Vitamin D insufficiency |
35,079 European ancestry cases, 140,898 European ancestry controls |
A |
0.383 |
1E-8 |
8 |
rs1532085 |
0.05 |
vitamin D deficiency (EFO:0003762)
|
PMID:34308111 |
GWAS1545710_H |
GCST90092934 |
Ratio of omega-6 fatty acids to omega-3 fatty acids |
115,006 European ancestry individuals |
A |
0.386032 |
3E-99 |
98.523 |
rs1532085 |
0.0862885 |
fatty acid measurement (EFO:0005110)
|
PMID:35213538 |
GWAS1549985_H |
GCST90029070 |
C-reactive protein levels |
575,531 European ancestry individuals |
A |
NR |
5E-13 |
12.302 |
rs1532085 |
0.0147 |
C-reactive protein measurement (EFO:0004458)
|
PMID:35459240 |
GWAS1575847_H |
GCST90025610 |
Phosphatidylethanolamine (18:0_22:5) (n3) levels |
4,492 European ancestry individuals |
G |
NR |
8E-42 |
41.097 |
rs1532085 |
0.306 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1576178_H |
GCST90025593 |
Phosphatidylethanolamine (16:0_18:3) (b) levels |
4,492 European ancestry individuals |
G |
NR |
2E-39 |
38.699 |
rs1532085 |
0.294 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1576181_H |
GCST90025594 |
Phosphatidylethanolamine (16:0_20:3) levels |
4,492 European ancestry individuals |
G |
NR |
1E-41 |
41 |
rs1532085 |
0.305 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
None Available |
GCST90025598 |
Phosphatidylethanolamine (16:1_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
2E-24 |
23.699 |
rs1532085 |
0.23 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1576773_H |
GCST012232 |
Lipoprotein (a) levels |
348,591 European ancestry individuals, 6,000 African ancestry individuals, 9,116 Asian ancestry individuals, 7,505 individuals |
A |
NR |
9E-10 |
9.046 |
rs1532085 |
0.008666 |
lipoprotein A measurement (EFO:0006925)
|
PMID:33730874 |
GWAS1576821_H |
GCST90025688 |
Phosphatidylglycerol (34:1) levels |
4,492 European ancestry individuals |
G |
NR |
1E-26 |
26 |
rs1532085 |
0.241 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
GWAS1576823_H |
GCST90025689 |
Phosphatidylglycerol (34:2) levels |
4,492 European ancestry individuals |
G |
NR |
7E-16 |
15.155 |
rs1532085 |
0.181 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
GWAS1579409_H |
GCST90024600 |
Total Phosphatidylglycerol levels |
4,492 European ancestry individuals |
G |
NR |
9E-27 |
26.046 |
rs1532085 |
0.241 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
GWAS1580414_H |
GCST90025585 |
Phosphatidylethanolamine (15-MHDA_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
8E-41 |
40.097 |
rs1532085 |
0.301 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1580416_H |
GCST90025586 |
Phosphatidylethanolamine (15-MHDA_20:4) levels |
4,492 European ancestry individuals |
G |
NR |
2E-41 |
40.699 |
rs1532085 |
0.302 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
None Available |
GCST90025588 |
Phosphatidylethanolamine (16:0_16:0) levels |
4,492 European ancestry individuals |
G |
NR |
4E-25 |
24.398 |
rs1532085 |
0.231 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1580717_H |
GCST90025591 |
Phosphatidylethanolamine (16:0_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
7E-45 |
44.155 |
rs1532085 |
0.316 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1580729_H |
GCST90025605 |
Phosphatidylethanolamine (18:0_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
4E-41 |
40.398 |
rs1532085 |
0.303 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
None Available |
GCST90024450 |
Phosphatidylglycerol (34:2) levels |
4,492 European ancestry individuals |
G |
NR |
2E-15 |
14.699 |
rs1532085 |
0.176 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
GWAS1580859_H |
GCST90024452 |
Phosphatidylglycerol (36:2) levels |
4,492 European ancestry individuals |
G |
NR |
3E-18 |
17.523 |
rs1532085 |
0.195 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
GWAS1581538_H |
GCST90024371 |
Phosphatidylethanolamine (18:0_22:5) (n3) levels |
4,492 European ancestry individuals |
G |
NR |
1E-47 |
47 |
rs1532085 |
0.325 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1582638_H |
GCST90024359 |
Phosphatidylethanolamine (16:1_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
4E-13 |
12.398 |
rs1532085 |
0.163 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1583224_H |
GCST90024366 |
Phosphatidylethanolamine (18:0_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
4E-44 |
43.398 |
rs1532085 |
0.314 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1584447_H |
GCST90024354 |
Phosphatidylethanolamine (16:0_18:3) (b) levels |
4,492 European ancestry individuals |
G |
NR |
3E-34 |
33.523 |
rs1532085 |
0.272 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1584474_H |
GCST90025207 |
Total Phosphatidylethanolamine levels |
6,057 European ancestry individuals |
G |
NR |
2E-82 |
81.699 |
rs1532085 |
N/A |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1584596_H |
GCST90010825 |
Phosphatidylcholine acyl-alkyl C34:1 levels |
16,838 Caucasian ancestry individuals |
A |
0.3768 |
3E-12 |
11.523 |
rs1532085 |
6.967 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:33414548 |
GWAS1584719_H |
GCST90024352 |
Phosphatidylethanolamine (16:0_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
3E-38 |
37.523 |
rs1532085 |
0.292 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
None Available |
GCST90024346 |
Phosphatidylethanolamine (15-MHDA_18:2) levels |
4,492 European ancestry individuals |
G |
NR |
9E-32 |
31.046 |
rs1532085 |
0.264 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1584724_H |
GCST90024347 |
Phosphatidylethanolamine (15-MHDA_20:4) levels |
4,492 European ancestry individuals |
G |
NR |
3E-30 |
29.523 |
rs1532085 |
0.256 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1584998_H |
GCST90024349 |
Phosphatidylethanolamine (16:0_16:0) levels |
4,492 European ancestry individuals |
G |
NR |
1E-18 |
18 |
rs1532085 |
0.196 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
GWAS1585120_H |
GCST90302129 |
Cholesteryl esters to total lipids ratio in very large HDL |
4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals |
A |
0.408 |
3E-244 |
243.523 |
rs1532085 |
0.1333 |
cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:38448586 |
GWAS1585159_H |
GCST90024449 |
Phosphatidylglycerol (34:1) levels |
4,492 European ancestry individuals |
G |
NR |
4E-20 |
19.398 |
rs1532085 |
0.206 |
glycerophospholipid measurement (EFO:0007630)
|
PMID:35668104 |
None Available |
GCST90024355 |
Phosphatidylethanolamine (16:0_20:3) levels |
4,492 European ancestry individuals |
G |
NR |
1E-36 |
36 |
rs1532085 |
0.286 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:35668104 |
None Available |
GCST90270117 |
Multi-trait sum score |
161,906 European ancestry females |
? |
NR |
2E-39 |
38.699 |
rs1532085 |
N/A |
complex trait (EFO:0010578)
|
PMID:37277458 |
None Available |
GCST90239609 |
Total cholesterol levels |
76,578 Taiwanese ancestry individuals |
? |
NR |
3E-34 |
33.523 |
rs1532085 |
2.10538 |
total cholesterol measurement (EFO:0004574)
|
PMID:36329257 |
None Available |
GCST90244868 |
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (p-18:0/18:2) levels |
14,296 European ancestry individuals |
A |
0.3863 |
7E-13 |
12.155 |
rs1532085 |
0.07537719 |
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement (EFO:0020014)
|
PMID:36357675 |
GWAS1593624_H |
GCST90250219 |
Protein Wnt-5a levels |
10,708 European ancestry individuals |
A |
0.38 |
7E-23 |
22.155 |
rs1532085 |
0.134 |
protein measurement (EFO:0004747)
|
PMID:34648354 |
None Available |
GCST90244959 |
1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) levels |
14,296 European ancestry individuals |
A |
0.3873 |
7E-10 |
9.155 |
rs1532085 |
0.06434421 |
1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) measurement (EFO:0800430)
|
PMID:36357675 |
GWAS1599129_H |
GCST90239610 |
Triglyceride levels |
76,053 Taiwanese ancestry individuals |
? |
NR |
7E-18 |
17.155 |
rs1532085 |
2.71526 |
triglyceride measurement (EFO:0004530)
|
PMID:36329257 |
GWAS1599230_H |
GCST90179149 |
Triglyceride levels (MTAG) |
361,194 European ancestry individuals |
A |
NR |
5E-11 |
10.302 |
rs1532085 |
0.016721 |
triglyceride measurement (EFO:0004530)
|
PMID:36376304 |
GWAS1601167_H |
GCST90102725 |
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels |
8,809 European ancestry individuals |
A |
NR |
2E-55 |
54.699 |
rs1532085 |
0.238 |
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement (EFO:0800608)
|
PMID:35050183 |
None Available |
GCST90277327 |
Phosphatidylcholine (O-16:1_18:1) levels |
7,154 Finnish ancestry individuals |
A |
0.426559 |
2E-8 |
7.699 |
rs1532085 |
0.0951275 |
level of Phosphatidylcholine (O-16:1_18:1) in blood serum (OBA:2045120)
|
PMID:37907536 |
GWAS1603680_H |
GCST90277328 |
Phosphatidylcholine (O-16:1_18:2) levels |
7,096 Finnish ancestry individuals |
A |
0.426559 |
9E-12 |
11.046 |
rs1532085 |
0.115334 |
level of Phosphatidylcholine (O-16:1_18:2) in blood serum (OBA:2045121)
|
PMID:37907536 |
GWAS1603947_H |
GCST90277281 |
Phosphatidylcholine (16:0_18:1) levels |
7,174 Finnish ancestry individuals |
A |
0.426559 |
6E-9 |
8.222 |
rs1532085 |
0.0977538 |
level of Phosphatidylcholine (16:0_18:1) in blood serum (OBA:2045070)
|
PMID:37907536 |
GWAS1604001_H |
GCST90277331 |
Phosphatidylcholine (O-16:2_18:0) levels |
6,672 Finnish ancestry individuals |
A |
0.426559 |
1E-23 |
23 |
rs1532085 |
0.174443 |
level of phosphatidylcholine (OBA:2040179)
|
PMID:37907536 |
None Available |
GCST90277269 |
Phosphatidylethanolamine (18:0_0:0) levels |
6,258 Finnish ancestry individuals |
A |
0.426559 |
2E-8 |
7.699 |
rs1532085 |
0.101106 |
level of Phosphatidylethanolamine (18:0_0:0) in blood serum (OBA:2045138)
|
PMID:37907536 |
None Available |
GCST90277308 |
Phosphatidylcholine (18:1_18:1) levels |
7,174 Finnish ancestry individuals |
A |
0.426559 |
7E-11 |
10.155 |
rs1532085 |
0.109594 |
level of Phosphatidylcholine (18:1_18:1) in blood serum (OBA:2045099)
|
PMID:37907536 |
GWAS1605245_H |
GCST90102790 |
2-stearoyl-GPE (18:0) levels |
8,809 European ancestry individuals |
A |
NR |
9E-18 |
17.046 |
rs1532085 |
0.132 |
2-stearoyl-GPE (18:0) measurement (EFO:0800343)
|
PMID:35050183 |
GWAS1605334_H |
GCST90277371 |
Sphingomyelin (d34:2) levels |
7,174 Finnish ancestry individuals |
A |
0.426559 |
8E-11 |
10.097 |
rs1532085 |
0.109151 |
level of Sphingomyelin (d34:2) in blood serum (OBA:2045174)
|
PMID:37907536 |
GWAS1608325_H |
GCST90269691 |
Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594) |
88,329 European ancestry individuals |
A |
0.386011 |
2E-107 |
106.699 |
rs1532085 |
0.102972 |
phospholipids:total lipids ratio (EFO:0020946)
|
PMID:36764567 |
None Available |
GCST90269703 |
Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606) |
88,329 European ancestry individuals |
A |
0.386011 |
1E-21 |
21 |
rs1532085 |
0.0439818 |
cholesteryl esters to total lipids in very small VLDL percentage (EFO:0022259)
|
PMID:36764567 |
None Available |
GCST90269549 |
Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452) |
88,268 European ancestry individuals |
A |
0.38604 |
8E-41 |
40.097 |
rs1532085 |
0.0624332 |
omega-6 polyunsaturated fatty acid measurement (EFO:0005680)
|
PMID:36764567 |
GWAS1610597_H |
GCST90269552 |
Saturated fatty acids to total fatty acids percentage (UKB data field 23455) |
88,268 European ancestry individuals |
A |
0.38604 |
3E-25 |
24.523 |
rs1532085 |
0.0495442 |
saturated fatty acids to total fatty acids percentage (EFO:0022305)
|
PMID:36764567 |
GWAS1612108_H |
GCST90269678 |
Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581) |
85,701 European ancestry individuals |
A |
0.384943 |
3E-66 |
65.523 |
rs1532085 |
0.0842016 |
cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022246)
|
PMID:36764567 |
GWAS1612113_H |
GCST90269679 |
Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582) |
85,701 European ancestry individuals |
A |
0.384943 |
1E-114 |
114 |
rs1532085 |
0.109955 |
free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022277)
|
PMID:36764567 |
GWAS1612409_H |
GCST90269677 |
Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580) |
85,701 European ancestry individuals |
A |
0.384943 |
8E-91 |
90.097 |
rs1532085 |
0.0984173 |
cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022232)
|
PMID:36764567 |
GWAS1612485_H |
GCST90269689 |
Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) |
88,321 European ancestry individuals |
A |
0.386012 |
2E-79 |
78.699 |
rs1532085 |
0.0909031 |
free cholesterol to total lipids in large VLDL percentage (EFO:0022281)
|
PMID:36764567 |
GWAS1612490_H |
GCST90269688 |
Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591) |
88,321 European ancestry individuals |
A |
0.386012 |
5E-133 |
132.302 |
rs1532085 |
0.114371 |
cholesteryl esters to total lipids in large VLDL percentage (EFO:0022250)
|
PMID:36764567 |
GWAS1612751_H |
GCST90269676 |
Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579) |
85,701 European ancestry individuals |
A |
0.384943 |
3E-152 |
151.523 |
rs1532085 |
0.127647 |
phospholipids:total lipids ratio (EFO:0020946)
|
PMID:36764567 |
GWAS1612815_H |
GCST90269680 |
Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583) |
85,701 European ancestry individuals |
A |
0.384943 |
2E-124 |
123.699 |
rs1532085 |
0.116103 |
triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (EFO:0022328)
|
PMID:36764567 |
GWAS1613152_H |
GCST90269684 |
Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587) |
87,620 European ancestry individuals |
A |
0.385682 |
3E-73 |
72.523 |
rs1532085 |
0.0852069 |
free cholesterol to total lipids in very large VLDL percentage (EFO:0022289)
|
PMID:36764567 |
GWAS1618808_H |
GCST90269713 |
Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) |
88,329 European ancestry individuals |
A |
0.386011 |
1E-54 |
54 |
rs1532085 |
0.0752546 |
cholesteryl esters to total lipids in large LDL percentage (EFO:0022249)
|
PMID:36764567 |
GWAS1618818_H |
GCST90269712 |
Cholesterol to total lipids in large LDL percentage (UKB data field 23615) |
88,329 European ancestry individuals |
A |
0.386011 |
6E-87 |
86.222 |
rs1532085 |
0.093238 |
cholesterol to total lipids in large LDL percentage (EFO:0022235)
|
PMID:36764567 |
None Available |
GCST90199791 |
1-arachidonoyl-GPE (20:4n6) levels |
8,270 European ancestry individuals |
G |
0.623395 |
5E-11 |
10.302 |
rs1532085 |
0.104314 |
1-arachidonoyl-GPE (20:4n6) measurement (EFO:0800248)
|
PMID:36635386 |
None Available |
GCST90269695 |
Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598) |
88,329 European ancestry individuals |
A |
0.386011 |
1E-36 |
36 |
rs1532085 |
0.0583281 |
triglycerides to total lipids in medium VLDL percentage (EFO:0022335)
|
PMID:36764567 |
GWAS1619837_H |
GCST90244284 |
Phosphatidylcholine (O-16:2_18:0) levels |
2,624 European ancestry men |
A |
NR |
4E-11 |
10.398 |
rs1532085 |
0.193022 |
level of phosphatidylcholine (OBA:2040179)
|
PMID:36193934 |
GWAS1620134_H |
GCST90200045 |
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels |
8,259 European ancestry individuals |
G |
0.623195 |
4E-115 |
114.398 |
rs1532085 |
0.351719 |
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement (EFO:0800403)
|
PMID:36635386 |
None Available |
GCST90249453 |
Sodium-coupled monocarboxylate transporter 1 levels |
10,708 European ancestry individuals |
A |
0.38 |
8E-12 |
11.097 |
rs1532085 |
0.094 |
sodium-coupled monocarboxylate transporter 1 measurement (EFO:0802076)
|
PMID:34648354 |
GWAS1620470_H |
GCST90200079 |
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) levels |
8,121 European ancestry individuals |
G |
0.62153 |
3E-116 |
115.523 |
rs1532085 |
0.358021 |
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement (EFO:0800470)
|
PMID:36635386 |
None Available |
GCST90199780 |
1-stearoyl-GPG (18:0) levels |
6,806 European ancestry individuals |
G |
0.62073 |
2E-10 |
9.699 |
rs1532085 |
0.112161 |
1-stearoyl-GPG (18:0) measurement (EFO:0800228)
|
PMID:36635386 |
None Available |
GCST90244230 |
Phosphatidylcholine (16:0_16:0) levels |
2,624 European ancestry men |
A |
NR |
6E-9 |
8.222 |
rs1532085 |
0.164469 |
level of Phosphatidylcholine (16:0_16:0) in blood serum (OBA:2045067)
|
PMID:36193934 |
GWAS1620835_H |
GCST90200054 |
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels |
8,257 European ancestry individuals |
G |
0.623104 |
1E-145 |
145 |
rs1532085 |
0.394729 |
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement (EFO:0800409)
|
PMID:36635386 |
GWAS1621491_H |
GCST90269733 |
Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) |
88,329 European ancestry individuals |
A |
0.386011 |
8E-16 |
15.097 |
rs1532085 |
0.0375237 |
cholesteryl esters to total lipids in large HDL percentage (EFO:0022248)
|
PMID:36764567 |
None Available |
GCST90269685 |
Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588) |
87,620 European ancestry individuals |
A |
0.385682 |
3E-38 |
37.523 |
rs1532085 |
0.0609493 |
triglycerides to total lipids in very large VLDL percentage (EFO:0022340)
|
PMID:36764567 |
GWAS1622112_H |
GCST90269687 |
Cholesterol to total lipids in large VLDL percentage (UKB data field 23590) |
88,321 European ancestry individuals |
A |
0.386012 |
1E-132 |
132 |
rs1532085 |
0.116471 |
cholesterol to total lipids in large VLDL percentage (EFO:0022236)
|
PMID:36764567 |
GWAS1622431_H |
GCST90269681 |
Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) |
87,620 European ancestry individuals |
A |
0.385682 |
3E-55 |
54.523 |
rs1532085 |
0.0757268 |
phospholipids:total lipids ratio (EFO:0020946)
|
PMID:36764567 |
GWAS1624853_H |
GCST90278644 |
Total cholesterol levels |
92,615 Taiwanese ancestry individuals |
? |
NR |
2E-40 |
39.699 |
rs1532085 |
N/A |
total cholesterol measurement (EFO:0004574)
|
PMID:38116116 |
None Available |
GCST90270119 |
Multi-trait sum score |
141,980 European ancestry males |
? |
NR |
4E-44 |
43.398 |
rs1532085 |
N/A |
complex trait (EFO:0010578)
|
PMID:37277458 |